DUSP12

Across TCGA pan-cancer cohorts, DUSP12 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated DUSP12 data layer compared with 24 for mass-spec protein and 4 for mass-spec protein.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher DUSP12 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated DUSP12 expression acts as an unfavorable survival marker.

ACC and COAD are the cancer types where DUSP12 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	OS	Median	All	0.273	0.802	.017	15	view →
COAD	DFS	Median	All	0.183	0.696	.004	12	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

DUSP12–ACC (OS)

Open the ACC breakdown →